Cardiovascular Surgery

This channel includes news and new technology innovations in cardiac surgery. This includes coronary artery bypass grafts (CABG), open chest structural heart surgical repairs and valve replacements, heart transplants, and placement of extracorporeal membrane oxygenation (ECMO), left ventricular assist devices (LVAD) and artificial hearts.

emporary Spinal cord stimulation (SCS) was effective in suppressing post-operative atrial fibrillation (AF) after coronary artery bypass (CAGB) surgery CABG without any adverse events in a randomized pilot study. The TEmporary Spinal CoRd StiMulatIon to PrevenNt Atrial FibrillaTION AFter Cardiac Surgery (TerminationAF) study was presented as a late-breaking study presented at the 2021 Heart Rhythm meeting, the annual conference of the Heart Rhythm Society (HRS).  #HRS21 #HRS2021
News | EP Lab | August 03, 2021
Spinal Cord Stimulation Helps Suppress AF in CABG Patients
August 4, 2021 — Temporary Spinal cord stimulation (SCS) was effective in suppressing post-operative atrial...
read more
Medtronic announced in June it was stopping the sale and distribution of the Medtronic Heartware HVAD left ventricular assist device (LVAD). Abbott announced the same day it has the capacity to meet increased demand for LVADs as Medtronic leaves the market.

Medtronic announced in June it was stopping the sale and distribution of the Medtronic Heartware HVAD left ventricular assist device (LVAD). Abbott announced the same day it has the capacity to meet increased demand for LVADs as Medtronic leaves the market.

Feature | Ventricular Assist Devices (VAD) | July 08, 2021 | By Dave Fornell, Editor
Medtronic Ends Sales of HVAD Ventricular Assist System
Medtronic announced in June it was stopping the sale and distribution of the Medtronic Heartware HVAD left ventricular...
read more
Surgical Site Infection (SSI) prevention remains a high priority for cardiac surgeons whose heroic efforts can be thwarted by infection. No matter how skilled a cardiac surgeon or how successful a surgery, when an SSI sets in, patients can find themselves fighting for their lives. While not unique to cardiovascular surgery, post-operative infections have severe repercussions for recovering heart surgery patients. Unfortunately, even with SSI prevention methods implemented, SSIs remain as common as 5% in car

Getty Images

Feature | Cardiovascular Surgery | June 24, 2021 | By Noam Emanuel, Ph.D.
Rethinking Heart Surgery Surgical Site Infection Prevention
Surgical Site Infection (SSI) prevention remains a high priority for cardiac surgeons whose heroic efforts can be...
read more
The Carmat system, an experimental artificial heart includes an autoregulation control mechanism, or Auto-Mode, that can adjust to the changing needs of patients treated for end-stage heart failure. Outcomes in the first series of patients managed with the new heart replacement pump in Auto-Mode are presented in the journal of the American Society for Artificial Internal Organs (ASAIO). 

The Carmat artificial heart technology.

News | Artificial Heart | June 23, 2021
Carmat Artificial Heart Shows Promising Automatic Regulation of Blood Flow
June 18, 2021 – An experimental artificial heart includes an autoregulation control mechanism, or Auto-Mode, that can...
read more
The LivaNova Percelval sutureless aortic valve and Solo Smart surgical aortic valve are part of heart valve portfolio the company sold off June 1 to Gyrus Capital and Corcym..

The LivaNova Percelval sutureless aortic valve and Solo Smart surgical aortic valve are part of heart valve portfolio the company sold off June 1.

News | Heart Valve Technology | June 02, 2021
LivaNova Sells Heart Valve Business to Gyrus Capital
June 2, 2021 – LivaNova announced June 1 it successfully completed the initial closing of the divestiture of its heart...
read more
In the LAAOS III trial, surgeons could seal off the LAA during the open heart procedure using sutures, staples or approved closure devices. The image shows a SentraHeart lasso type LAA occluder about to seal off the LAA from the outside of the heart. #ACC21 #ACC2021

In the LAAOS III trial, surgeons could seal off the LAA during the open heart procedure using sutures, staples or approved closure devices. The image shows a SentraHeart lasso type LAA occluder about to seal off the LAA from the outside of the heart. 

News | Left Atrial Appendage (LAA) Occluders | May 15, 2021
Left Atrial Appendage Occlusion Reduces Stroke After Heart Surgery
May 15, 2021 — Patients with an elevated risk of stroke due to heart rhythm problems, or atrial fibrillation (AFib),...
read more
If MitraClip Fails 95 Percent of Patients Will Need Full Surgical Valve Replacement according to a late-breaking study at the AATS 2021 meeting. #AATS2021

If MitraClip fails and a surgical repair is required, a late-breaking study presented at the 2021 AATS meeting showed 95 percent of patients will require a full surgical valve replacement.

News | Heart Valve Technology | May 04, 2021
If MitraClip Fails 95 Percent of Patients Will Need Surgical Valve Replacement
May 4, 2021 – A new study, presented at the 2021 American Association for Thoracic Surgery (AATS) 101st annual meeting...
read more
The Transmedics Organ Care System (OCS) Heart, or “Heart in a Box,” enables transplant surgeons to travel to much farther destinations to procure transplant hearts by acting as a miniature intensive care unit that keeps the heart alive.

The Transmedics Organ Care System (OCS) Heart, or “Heart in a Box,” enables transplant surgeons to travel to much farther destinations to procure transplant hearts by acting as a miniature intensive care unit that keeps the heart alive.

News | Cardiovascular Surgery | April 05, 2021
Heart in a Box Technology Expands Heart Transplant Window
April 5, 2021 — Smidt Heart Institute transplant surgeons Dominic Emerson, M.D., and Pedro Catarino, M.D. know how to...
read more
Videos | Ventricular Assist Devices (VAD) | March 22, 2021
VIDEO: New LVAD Designed to Prevent Hemolysis and Clots
Surgeons at Penn State Heart and Vascular Institute were the second group in the nation to implant a newly-designed...
read more
University of Minnesota researchers used a hybrid of tissue engineering and regenerative medicine to create heart valves that can grow with the recipient. When implanted in lambs, researchers showed that the tri-tube valves worked better than current animal-derived valves with almost none of the calcification or blood clotting that the other valves showed. This can be implanted in pediatric patients with congenital heart diseas. Photo from Syedain, et al., Tranquillo Lab, University of Minnesota

University of Minnesota researchers used a hybrid of tissue engineering and regenerative medicine to create heart valves that can grow with the recipient. When implanted in lambs, researchers showed that the tri-tube valves worked better than current animal-derived valves with almost none of the calcification or blood clotting that the other valves showed. Photo from Syedain, et al., Tranquillo Lab, University of Minnesota

News | Heart Valve Technology | March 18, 2021
Lab-created Heart Valves Can Grow With the Patient
March 18, 2020 — A groundbreaking new study led by University of Minnesota Twin Cities researchers from both the...
read more
LVAD patient Richard Huggins with the external control and power unit for his new EvaHeart2 left ventricular assist device at Penn State Health's Hershey Medical Center. 

LVAD patient Richard Huggins with the external control and power unit for his new EvaHeart2 left ventricular assist device at Penn State Health's Hershey Medical Center. 

News | Heart Failure | March 02, 2021
Hershey Medical Center Second in the Nation to Implant EvaHeart2 LVAD
March 2, 2021 — Penn State Health Milton S. Hershey Medical Center became the second hospital in the nation to implant...
read more
Medtronic Recalls HVAD Pump Implant Kits After 2 Deaths and 19 Serious Injuries
News | Ventricular Assist Devices (VAD) | March 01, 2021
Medtronic Recalls HVAD Pump Implant Kits After 2 Deaths and 19 Serious Injuries
March 1, 2021 — Medtronic is recalling the HeartWare Ventricular Assist Device (HVAD) Pump Implant Kit because the left...
read more
Two types of cardiac output monitoring. Left, is the lithium dilution technology is used to monitor and optimize hemodynamics. Show here is the LiDCOplus technology. Right, an example of an invasive pulmonary artery (PA) catheter used for invasive right heart hemodynamic monitoring.

Two types of cardiac output monitoring. Left, is the lithium dilution technology is used to monitor and optimize hemodynamics. Show here is the LiDCOplus technology. Right, an example of an invasive pulmonary artery (PA) catheter used for right heart hemodynamic monitoring.

Feature | Hemodynamic Monitoring Systems | February 23, 2021
Trends in Cardiac Output Monitoring Device Technologies
The overall trend in the cardiac output monitoring market is a movement toward noninvasive or minimally monitoring...
read more
The Carmat artificial heart
News | Artificial Heart | February 10, 2021
FDA OKs Use New Version of Carmat Artificial Heart in U.S. Early Feasibility Study
February 10, 2021 - The U.S. Food and Drug Administration (FDA) has granted artificial heart developer Carmat approval...
read more
The FineHeart Transcutaneous Energy Transfer (TET) System for the ICOMS cardiac assist device. 1. The ICOMS heart pump. 2. The implanted TET transfer pad. 3. The external energy transfer pad.

The FineHeart Transcutaneous Energy Transfer (TET) System for the ICOMS cardiac assist device. 1. The ICOMS heart pump. 2. The implanted TET transfer pad. 3. The external energy transfer pad.

News | Heart Failure | January 13, 2021
Wireless Transcutaneous Energy Transfer (TET) System for Powering a LVAD is Successful
January 13, 2021 — FineHeart, a preclinical-stage medical device company developing a novel left ventricular assist...
read more
© Copyright Wainscot Media. All Rights Reserved.